Seeking Alpha

Weight-loss stocks Arena Pharmaceuticals (ARNA) and Orexigen Therapeutics (OREX) are on the...

Weight-loss stocks Arena Pharmaceuticals (ARNA) and Orexigen Therapeutics (OREX) are on the radar of traders after rival Vivus (VVUS) lands a 3-month PDUA extension from the FDA for Qnexa. The decision pushes back the target date for the agency to consider the closely-watched drug's safety plan to July 17 from April 17. Premarket: ARNA +2.6%, OREX +2.3%, VVUS -7.9%.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|